Clinical Trials Browser

Completed × Breast Neoplasms × Sunitinib × Clear all

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00656669 2023-05-23

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

Phase NA Completed

23 enrolled 12 charts

Breast Neoplasms

NCT00270413 2022-11-22

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Phase NA Completed

223 enrolled 8 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT00887575 2016-09-07

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Phase 1/2 Completed

54 enrolled 11 charts

Breast Neoplasms

NCT00662025 2013-05-27

Study Of Sunitinib With Capecitabine In Breast Cancer

Phase 2 Completed

63 enrolled 24 charts

Breast Neoplasms

NCT00372424 2012-12-28

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Phase 1 Completed

26 enrolled 10 charts

Breast Neoplasms

NCT00393939 2012-07-19

SUN 1064

Phase 3 Completed

594 enrolled 11 charts

Breast Neoplasms

NCT00246571 2012-07-12

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Phase 2 Completed

217 enrolled 24 charts

Breast Neoplasms

NCT00435409 2012-06-26

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

Phase 3 Completed

442 enrolled 12 charts

Breast Neoplasms

NCT00471276 2011-07-25

Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

Phase 2 Completed

83 enrolled 26 charts

Breast Neoplasms

NCT00243503 2011-07-22

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Phase 2 Completed

60 enrolled 18 charts

Breast Neoplasms

NCT00291577 2009-12-23

Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

Phase 1 Completed

22 enrolled 20 charts

Breast Neoplasms

NCT00174434 2009-01-27

Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT00078000 2008-11-26

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Phase 2 Completed

Breast Neoplasms